MSH-Release Inhibiting Factor [MIF]

• Short Description:

  Catalog Number: MDP0361 (10 mg) MSH-Release Inhibiting Factor [MIF] is a high quality MSH-Release Inhibiting Factor [MIF]. This product has been used as molecular tool for various biochemical applications. It has also been used in a wide array of other chemical and immunological applications. Custom bulk amounts of this product are available upon request.

• Description:

  MSH-Release Inhibiting Factor [MIF] Catalog number: MDP0361 CAS Number: 81039-85-2 Sequence: Pro-Leu-Gly-NH2 . 1/ 2H2O Amount: 10 mg Molecular Weight: 284 g/mol Supplied as: Powder Applications: molecular tool for various biochemical applications Storage: -20 °C WARNING: For in vitro Research Use Only. NOT for use on humans or animals. Grade: Biotechnology grade. All products are highly pure. References: 1: López-Contreras AM, Martínez-Liarte JH, Solano F, Samaraweera P, Newton JM, Bagnara JT. The amphibian melanization inhibiting factor (MIF) blocks the alpha-MSH effect on mouse malignant melanocytes Pigment Cell Res. 1996 Dec;9(6):311-6. 2: Kastin AJ, Hahn K, Zadina JE, Banks WA, Hackler L. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate J Neurochem. 1995 Apr;64(4):1855-9. 3: Tilders FJ, van der Woude HA, Swaab DF, Mulder AH. Identification of MSH release-inhibiting elements in the neurointermediate lobe of the rat Brain Res. 1979 Aug 10;171(3):425-35. 4: Zuasti A. Melanization stimulating factor (MSF) and melanization inhibiting factor (MIF) in the integument of fish Microsc Res Tech. 2002 Sep 15;58(6):488-95. 5: Carolei A, Margotta V, Palladini G. Melanocyte-stimulating hormone release-inhibiting factor (MIF): lack of dopaminergic and anticholinergic activity Neuroendocrinology. 1977;23(3):129-32. 6: Kastin AJ, Schally AV, Kostrzewa RM. Possible aminergic mediation of MSH release and of the CNS effects of MSH and MIF-I Fed Proc. 1980 Sep;39(11):2931-6. 7: Pugsley TA, Lippmann W. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover Arzneimittelforschung. 1977;27(12):2293-6. 8: Verburg-van Kemenade BM, Jenks BG, Danger JM, Vaudry H, Pelletier G, Saint-Pierre S. An NPY-like peptide may function as MSH-release inhibiting factor in Xenopus laevis Peptides. 1987 Jan-Feb;8(1):61-7. 9: Voigt KH, Fehm HL, Lang RE, Beinert KE, Pfeiffer EF. Suppression of ACTH secretion by synthetic MSH-release inhibiting factor Pro-Leu-Gly-NH2 in Addison's disease Horm Metab Res. 1977 Mar;9(2):150-2. 10: Reichlin S, Saperstein R, Jackson IM, Boyd AE 3rd, Patel Y. Hypothalamic hormones Annu Rev Physiol. 1976;38:389-424.
  Products Related to MSH-Release Inhibiting Factor [MIF] can be found at Peptides

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height :

  0.5